查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1886287

生技合約生產市場－全球產業規模、佔有率、趨勢、機會和預測，按服務、類型、營運規模、治療領域、地區和競爭格局分類，2020-2030年預測

Biotechnology Contract Manufacturing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Service, By Type, By Scale of Operation, By Therapeutic Area, By Region and Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024年全球生技合約生產市場規模為221.5億美元，預計2030年將以7.48%的複合年成長率成長至341.5億美元。生技合約生產是指將藥物研發和生產的專業服務外包給第三方機構，使生物製藥公司能夠專注於研發等核心競爭力。這些服務通常包括細胞株開發、製程最佳化、生產、製劑、填充和包裝等。

市場概覽
預測期 2026-2030
市場規模：2024年 221.5億美元
市場規模：2030年 341.5億美元
複合年成長率：2025-2030年 7.48%
成長最快的細分市場 製造業
最大的市場 北美洲

主要市場促進因素

全球生物技術合約生產市場受到生物製劑和先進療法需求不斷成長的顯著影響。對包括單株抗體、細胞和基因療法在內的複雜生物製品的日益關注，促使生物製藥公司尋求合約研發生產機構的專業技術和先進的生產能力。

主要市場挑戰

智慧財產權（IP）領域的複雜性對全球生物技術合約生產市場的成長構成了重大挑戰。生物製藥公司在與第三方機構合作時，必須謹慎處理專有資訊的保護和共享問題，這通常涉及複雜的協議和高昂的法律成本。

主要市場趨勢

一個顯著的趨勢是全球供應鏈韌性的增強和分散式生產的推進。生物製藥公司正積極尋求降低地緣政治不穩定和物流挑戰帶來的風險，從而增加對更在地化和多元化生產網路的投資。

目錄

第1章：產品概述

第2章：研究方法

第3章：執行概要

第4章：客戶之聲

第5章：全球生物技術合約生產市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依服務項目分類（生產、配方及灌裝、包裝及貼標、其他服務）
    • 依類型（生物藥物原料生產、生物藥物製劑生產）
    • 依營運規模（商業營運、臨床營運）分類
    • 依治療領域分類（自體免疫疾病、心血管疾病、代謝性疾病、傳染病、神經病學、其他治療領域）
    • 按地區
    • 按公司（2024 年）
  • 市場地圖

第6章：北美生物技術合約製造市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲生物技術合約製造市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太生物技術合約生產市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲生物技術合約製造市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲生物技術合約製造市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章：市場動態

  • 促進要素
  • 挑戰

第12章：市場趨勢與發展

  • 併購
  • 產品發布
  • 最新進展

第13章：全球生技合約製造市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商議價能力
  • 顧客的力量
  • 替代產品的威脅

第15章：競爭格局

  • Lonza Group Ltd.
  • Thermo Fisher Scientific, Inc.
  • Wuxi Biologics Co., Ltd.
  • Catalent, Inc.
  • Samsung Biologics Co., Ltd.
  • Boehringer Ingelheim International GmbH
  • Fujifilm Holdings Corporation
  • Abbvie Inc.
  • Eurofins Scientific SE
  • Genscript Biotech Corporation

第16章：策略建議

第17章調查會社について,免責事項

簡介目錄
Product Code: 22272

The Global Biotechnology Contract Manufacturing Market, valued at USD 22.15 Billion in 2024, is projected to experience a CAGR of 7.48% to reach USD 34.15 Billion by 2030. Biotechnology contract manufacturing involves the outsourcing of specialized services for drug development and manufacturing to third-party organizations, enabling biopharmaceutical companies to concentrate on core competencies such as research and development. These services typically encompass cell line development, process optimization, manufacturing, formulation, fill-finish operations, and packaging.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 22.15 Billion
Market Size 2030USD 34.15 Billion
CAGR 2025-20307.48%
Fastest Growing SegmentManufacturing
Largest MarketNorth America

Key Market Drivers

The global biotechnology contract manufacturing market is significantly shaped by the escalating demand for biologics and advanced therapies. This growing focus on complex biological products, including monoclonal antibodies and cell and gene therapies, drives biopharmaceutical companies to seek specialized expertise and advanced manufacturing capabilities from contract development and manufacturing organizations.

Key Market Challenges

The intricate landscape of intellectual property (IP) rights presents a significant challenge to the growth of the Global Biotechnology Contract Manufacturing Market. Biopharmaceutical companies engaging third-party organizations must meticulously navigate the protection and sharing of proprietary information, which often involves complex agreements and substantial legal costs. This complexity introduces hesitancy and can delay outsourcing decisions for critical drug development and manufacturing projects, directly impacting market expansion.

Key Market Trends

A significant trend involves the strengthening of global supply chain resilience and the move towards distributed manufacturing. Biopharmaceutical companies are actively seeking to mitigate risks associated with geopolitical instabilities and logistical challenges, driving investments in more localized and diversified production networks. According to Cytiva's 2023 Global Biopharma Resilience Index, overall supply chain resilience improved slightly from 6.72 in 2021 to 6.84 in 2023, indicating ongoing industry efforts to fortify manufacturing capabilities.

Key Market Players

  • Lonza Group Ltd.
  • Thermo Fisher Scientific, Inc.
  • Wuxi Biologics Co., Ltd.
  • Catalent, Inc.
  • Samsung Biologics Co., Ltd.
  • Boehringer Ingelheim International GmbH
  • Fujifilm Holdings Corporation
  • Abbvie Inc.
  • Eurofins Scientific SE
  • Genscript Biotech Corporation

Report Scope:

In this report, the Global Biotechnology Contract Manufacturing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Biotechnology Contract Manufacturing Market, By Service:

  • Manufacturing
  • Formulation and Fill-Finish
  • Packaging and Labeling
  • Other services

Biotechnology Contract Manufacturing Market, By Type:

  • Biologic Drug Substance Manufacturing
  • Biologic Drug ProductManufacturing

Biotechnology Contract Manufacturing Market, By Scale of Operation:

  • Commercial Operations
  • Clinical Operations

Biotechnology Contract Manufacturing Market, By Therapeutic Area:

  • Autoimmune Diseases
  • Cardiovascular Diseases
  • Metabolic Diseases
  • Infectious Diseases
  • Neurology
  • Other Therapeutic Areas

Biotechnology Contract Manufacturing Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Biotechnology Contract Manufacturing Market.

Available Customizations:

Global Biotechnology Contract Manufacturing Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Biotechnology Contract Manufacturing Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Service (Manufacturing, Formulation and Fill-Finish, Packaging and Labeling, Other services)
    • 5.2.2. By Type (Biologic Drug Substance Manufacturing, Biologic Drug ProductManufacturing)
    • 5.2.3. By Scale of Operation (Commercial Operations, Clinical Operations)
    • 5.2.4. By Therapeutic Area (Autoimmune Diseases, Cardiovascular Diseases, Metabolic Diseases, Infectious Diseases, Neurology, Other Therapeutic Areas)
    • 5.2.5. By Region
    • 5.2.6. By Company (2024)
  • 5.3. Market Map

6. North America Biotechnology Contract Manufacturing Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Service
    • 6.2.2. By Type
    • 6.2.3. By Scale of Operation
    • 6.2.4. By Therapeutic Area
    • 6.2.5. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Biotechnology Contract Manufacturing Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Service
        • 6.3.1.2.2. By Type
        • 6.3.1.2.3. By Scale of Operation
        • 6.3.1.2.4. By Therapeutic Area
    • 6.3.2. Canada Biotechnology Contract Manufacturing Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Service
        • 6.3.2.2.2. By Type
        • 6.3.2.2.3. By Scale of Operation
        • 6.3.2.2.4. By Therapeutic Area
    • 6.3.3. Mexico Biotechnology Contract Manufacturing Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Service
        • 6.3.3.2.2. By Type
        • 6.3.3.2.3. By Scale of Operation
        • 6.3.3.2.4. By Therapeutic Area

7. Europe Biotechnology Contract Manufacturing Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Service
    • 7.2.2. By Type
    • 7.2.3. By Scale of Operation
    • 7.2.4. By Therapeutic Area
    • 7.2.5. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Biotechnology Contract Manufacturing Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Service
        • 7.3.1.2.2. By Type
        • 7.3.1.2.3. By Scale of Operation
        • 7.3.1.2.4. By Therapeutic Area
    • 7.3.2. France Biotechnology Contract Manufacturing Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Service
        • 7.3.2.2.2. By Type
        • 7.3.2.2.3. By Scale of Operation
        • 7.3.2.2.4. By Therapeutic Area
    • 7.3.3. United Kingdom Biotechnology Contract Manufacturing Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Service
        • 7.3.3.2.2. By Type
        • 7.3.3.2.3. By Scale of Operation
        • 7.3.3.2.4. By Therapeutic Area
    • 7.3.4. Italy Biotechnology Contract Manufacturing Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Service
        • 7.3.4.2.2. By Type
        • 7.3.4.2.3. By Scale of Operation
        • 7.3.4.2.4. By Therapeutic Area
    • 7.3.5. Spain Biotechnology Contract Manufacturing Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Service
        • 7.3.5.2.2. By Type
        • 7.3.5.2.3. By Scale of Operation
        • 7.3.5.2.4. By Therapeutic Area

8. Asia Pacific Biotechnology Contract Manufacturing Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Service
    • 8.2.2. By Type
    • 8.2.3. By Scale of Operation
    • 8.2.4. By Therapeutic Area
    • 8.2.5. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Biotechnology Contract Manufacturing Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Service
        • 8.3.1.2.2. By Type
        • 8.3.1.2.3. By Scale of Operation
        • 8.3.1.2.4. By Therapeutic Area
    • 8.3.2. India Biotechnology Contract Manufacturing Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Service
        • 8.3.2.2.2. By Type
        • 8.3.2.2.3. By Scale of Operation
        • 8.3.2.2.4. By Therapeutic Area
    • 8.3.3. Japan Biotechnology Contract Manufacturing Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Service
        • 8.3.3.2.2. By Type
        • 8.3.3.2.3. By Scale of Operation
        • 8.3.3.2.4. By Therapeutic Area
    • 8.3.4. South Korea Biotechnology Contract Manufacturing Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Service
        • 8.3.4.2.2. By Type
        • 8.3.4.2.3. By Scale of Operation
        • 8.3.4.2.4. By Therapeutic Area
    • 8.3.5. Australia Biotechnology Contract Manufacturing Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Service
        • 8.3.5.2.2. By Type
        • 8.3.5.2.3. By Scale of Operation
        • 8.3.5.2.4. By Therapeutic Area

9. Middle East & Africa Biotechnology Contract Manufacturing Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Service
    • 9.2.2. By Type
    • 9.2.3. By Scale of Operation
    • 9.2.4. By Therapeutic Area
    • 9.2.5. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Biotechnology Contract Manufacturing Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Service
        • 9.3.1.2.2. By Type
        • 9.3.1.2.3. By Scale of Operation
        • 9.3.1.2.4. By Therapeutic Area
    • 9.3.2. UAE Biotechnology Contract Manufacturing Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Service
        • 9.3.2.2.2. By Type
        • 9.3.2.2.3. By Scale of Operation
        • 9.3.2.2.4. By Therapeutic Area
    • 9.3.3. South Africa Biotechnology Contract Manufacturing Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Service
        • 9.3.3.2.2. By Type
        • 9.3.3.2.3. By Scale of Operation
        • 9.3.3.2.4. By Therapeutic Area

10. South America Biotechnology Contract Manufacturing Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Service
    • 10.2.2. By Type
    • 10.2.3. By Scale of Operation
    • 10.2.4. By Therapeutic Area
    • 10.2.5. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Biotechnology Contract Manufacturing Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Service
        • 10.3.1.2.2. By Type
        • 10.3.1.2.3. By Scale of Operation
        • 10.3.1.2.4. By Therapeutic Area
    • 10.3.2. Colombia Biotechnology Contract Manufacturing Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Service
        • 10.3.2.2.2. By Type
        • 10.3.2.2.3. By Scale of Operation
        • 10.3.2.2.4. By Therapeutic Area
    • 10.3.3. Argentina Biotechnology Contract Manufacturing Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Service
        • 10.3.3.2.2. By Type
        • 10.3.3.2.3. By Scale of Operation
        • 10.3.3.2.4. By Therapeutic Area

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Biotechnology Contract Manufacturing Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Lonza Group Ltd.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Thermo Fisher Scientific, Inc.
  • 15.3. Wuxi Biologics Co., Ltd.
  • 15.4. Catalent, Inc.
  • 15.5. Samsung Biologics Co., Ltd.
  • 15.6. Boehringer Ingelheim International GmbH
  • 15.7. Fujifilm Holdings Corporation
  • 15.8. Abbvie Inc.
  • 15.9. Eurofins Scientific SE
  • 15.10. Genscript Biotech Corporation

16. Strategic Recommendations

17. About Us & Disclaimer